Insights
Search Results
Alerts
5.29.26
Insights from the 2026 FTC Workshop on Last-Minute Antitrust Remedy Proposals
On May 20, 2026, the Federal Trade Commission (FTC) hosted “Eleventh-Hour Antitrust Remedy Proposals and Litigating the Fix” Workshop, which provided meaningful insight into how the agency is likely to approach merger remedies under its current leadership. Chairman Andrew Ferguson delivered the opening remarks, and Commissioner Mark Meador gave the closing remarks.
Alerts
1.22.26
2026 Antitrust Year in Preview
Last year was a landmark in the development of antitrust law. Enforcers, legislators, and private parties grappled with the fundamental shift represented by artificial intelligence (AI) technologies, the resolution of important digital technology antitrust cases, and significant divergence in policy across a presidential administration transition. The changes will not stop in 2026. In this preview, we focus on several economic sectors that were most impacted by developments in antitrust law in 2025 to identify the trends that will drive governmental and private activity in antitrust in 2026.
Alerts
1.22.26
2026 Antitrust Year in Preview: Big Tech
This update focuses on the digital technology sectors and the firms that have come to be collectively known as “Big Tech.” Our AI Industry Preview discusses the outlook for firms, including digital technology incumbents, working to innovate and compete in AI technologies, infrastructure, and applications.
Alerts
10.13.25
Impacts on U.S. Antitrust Enforcement as the Shutdown Takes Hold
The federal government shut down at 12:01 a.m. ET on Wednesday, October 1, 2025, triggering a pause of many “non-excepted” federal operations. Both the U.S. Department of Justice (DOJ) and the Federal Trade Commission (FTC) have enacted their published contingency plans and reduced staff accordingly. In accordance with directives in the agency contingency plans, agency lawyers have paused enforcement activity that is not deemed time sensitive and sought (with mixed success) to stay litigation or continue certain filing deadlines.
Client Highlights
8.25.25
Wilson Sonsini Represents BrightSpring as Divestiture Buyer for UnitedHealth/Amedisys Merger
On August 7, 2025, UnitedHealth Group and Amedisys agreed to a proposed settlement with the Department of Justice (DOJ) that clears the way for approval of their proposed $3.3 billion merger. The settlement, filed with the U.S. District Court for the District of Maryland, requires UnitedHealth and Amedisys to divest certain businesses to alleviate DOJ concerns about the merger being anticompetitive. Wilson Sonsini Goodrich & Rosati’s antitrust and competition practice is advising BrightSpring Health Services, a leading provider of home and community-based health services for complex populations, on the acquisition of more than 115 home health and hospice branches in 19 states from UnitedHealth and Amedisys as part of this divestiture.
Wilson Sonsini’s antitrust team represented BrightSpring in the litigation while simultaneously advocating for the settlement in front of the DOJ. The team includes Maureen Ohlhausen, Michelle Yost Hale, Kimberley Biagioli, Lindsey Edwards, and Miata Eggerly.
For more information, please see the DOJ’s news release on the settlement. Additional coverage is available from Reuters and Healthcare Dive.
Wilson Sonsini’s antitrust team represented BrightSpring in the litigation while simultaneously advocating for the settlement in front of the DOJ. The team includes Maureen Ohlhausen, Michelle Yost Hale, Kimberley Biagioli, Lindsey Edwards, and Miata Eggerly.
For more information, please see the DOJ’s news release on the settlement. Additional coverage is available from Reuters and Healthcare Dive.